Zoetis Priced, NYSE: ZTS
Spin-off of Pfizer's global animal health medicines and vaccines business.
Industry: Health Care
First Day Return: +19.3%
Industry: Health Care
ZTS
Spin-off of Pfizer's global animal health medicines and vaccines business.
| IPO Data | |
|---|---|
| IPO File Date | 08/13/2012 |
| Offer Price | $26.00 |
| Price Range $22.00 - $25.00 | |
| Offer Shares (mm) | 86.1 |
| Deal Size ($mm) | $2,239 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 01/31/2013 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $2,239 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Madison, NJ, United States |
| Founded | 1952 |
| Employees at IPO | 9,500 |
| Website www.zoetis.com | |
IPO News for Zoetis
Zoetis (ZTS) Performance
